Company intelligence / Profile preview

resistanceBio

Menlo Park, California, United Statesresistance.bio ↗

Ownership: Private
Development stage: Preclinical

Overview

resistanceBio develops advanced biotechnology platforms that mimic the evolution of drug resistance in human cancers. Their ENCER models are used to identify mechanisms of treatment resistance, discover novel targets, predict clinical outcomes, and improve the selection of drug candidates for further development. The company's approach aims to enable longer-lasting drugs by prioritizing understanding and prevention of drug resistance from early stages in oncology R&D. No direct clinical results reported as they primarily provide research tools/platforms for other companies' pipelines[1][2].

Therapeutic areas: Oncology
Modalities: Not explicitly stated; company focuses on cancer models and drug development support rather than direct therapeutic modalities[1][2].
Industry: Drug Discovery Services

Partnerships

Collaborations with academic institutions, research organizations, and pharmaceutical companies are mentioned but not specified by name[4].

Beyond the preview

Go deeper on resistanceBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on resistanceBio.

Explore the full profile